Takeda eyes emerging markets asset sale to trim its debt; report

Takeda eyes emerging markets asset sale to trim its debt; report

Source: 
Pharmaforum
snippet: 

Takeda is said to be considering the sale of assets in emerging markets and western Europe to pay down some of the debt it has taken on with the $62 billion acquisition of Shire.